CNS Pharmaceuticals (CNSP) Shares Outstanding (2018 - 2025)
CNS Pharmaceuticals' (CNSP) quarterly Shares Outstanding (Entity) came in at $443369.0 in Q4 2025, up 1291.97% YoY from $31852.0 in Q4 2024, and down 22.84% on a QoQ basis from $574580.0 in Q3 2025.
CNS Pharmaceuticals (CNSP) Shares Outstanding (2018 - 2025) Analysis & Trends
CNS Pharmaceuticals (CNSP) has 8 years of Shares Outstanding (Entity) data on file, last reported at $443369.0 in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 1291.97% year-over-year to $443369.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $443369.0 (up 1291.97% YoY) and the FY2025 annual result came in at $443369.0, up 1291.97% from the prior year.
- Shares Outstanding (Entity) declined to $443369.0 in Q4 2025, from $574580.0 in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $574580.0 in Q3 2025 to a low of $28.0 in Q1 2021.
- A 5-year average of $85197.6 and a median of $132.0 in 2023 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) surged 41.94% — and 2025, when it soared 84505.17%.
- Tracing CNSP's Shares Outstanding (Entity) over 5 years: stood at $31.0 in 2021, then jumped by 74.19% to $54.0 in 2022, then soared by 133.33% to $126.0 in 2023, then surged by 25179.37% to $31852.0 in 2024, then jumped by 1291.97% to $443369.0 in 2025.
- The last three Shares Outstanding (Entity) figures came in at $443369.0 (Q4 2025), $574580.0 (Q3 2025), and $370127.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | CNS Pharmaceuticals | 2.65 Mn | -4.55 Mn | - | 443,369.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 443,369.00 |
| Sep 30, 2025 | 558,868.00 |
| Jun 30, 2025 | 370,127.00 |
| Mar 31, 2025 | 227,211.00 |
| Dec 31, 2024 | 31,852.00 |
| Sep 30, 2024 | 36,967.00 |
| Jun 30, 2024 | 628.00 |
| Mar 31, 2024 | 290.00 |
| Dec 31, 2023 | 126.00 |
| Sep 30, 2023 | 139.00 |
| Jun 30, 2023 | 129.00 |
| Mar 31, 2023 | 64.00 |
| Dec 31, 2022 | 45.00 |
| Sep 30, 2022 | 44.00 |
| Jun 30, 2022 | 44.00 |
| Mar 31, 2022 | 43.00 |
| Dec 31, 2021 | 29.00 |
| Sep 30, 2021 | 30.00 |
| Jun 30, 2021 | 28.00 |
| Mar 31, 2021 | 27.00 |